Disc Medicine, Inc. (IRON) News
Track canonical SquawkNews coverage tagged to IRON, Disc Medicine, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 6 indexed stories across 4 publication days and is ordered by the same first-publication timeline used by LiveCast.
H
Truist Reiterates Buy On IRON
Truist reiterates buy rating on IRON
EQUITY | Jul 31, 2026, 01:00 PM UTC
M
IRON Disc Medicine Ends Q2 With $717.7M Cash
IRON Disc Medicine has $717.7M in cash and securities
EQUITY | Jul 30, 2026, 12:37 PM UTC
L
IRON - Disc Medicine Reports Second Quarter 2026 Financial Results and Provides Business Update
IRON - Disc Medicine Reports Second Quarter 2026 Financial Results and Provides Business Update
EARNINGS | Jul 30, 2026, 12:31 PM UTC
L
IRON Disc Medicine RESULTS: Q2, Q2 basic EPS $-1.54 vs. EST $-1.75, Q2 operating expenses $65.075M, Q2 Operating Income $-65.075M vs. EST $
IRON Disc Medicine RESULTS: Q2, Q2 basic EPS $-1.54 vs. EST $-1.75, Q2 operating expenses $65.075M, Q2 Operating Income $-65.075M vs. EST $-71M, Q2 Net Income $-59.532M vs. EST $-68.2M
EARNINGS | Jul 30, 2026, 12:31 PM UTC
L
Disc Medicine Insider Sold Shares Worth $2,473,780, According to a Recent SEC Filing
() -- John D Quisel, Director and Chief Executive Officer, on July 13, 2026, sold 33,000 shares in Disc Medicine (IRON) for $2,473,780. Following the Form 4 filing with the SEC, Quisel has control over a total of 226,064
REGULATION | Jul 15, 2026, 08:05 AM UTC
M
12 Health Care Stocks Move
Gainers Universe Pharmaceuticals (NASDAQ: UPC ) stock moved upwards by 168.2% to $7.94 during Friday's after-market session. The market value of their outstanding shares is at $1.8 million. Tvardi Therapeutics (NASDAQ: T
EQUITY | Jun 26, 2026, 11:20 PM UTC